{"text": ["Biogen&apos;s", "Multiple", "Sclerosis", "Drug", "Franchise", "Takes", "Another", "Hit"], "created_at": "2018-02-26 21:35:46"}
{"text": ["What\u2019s", "Expected", "for", "Novo", "Nordisk\u2019s", "Net", "Income", "Margin", "in", "2018"], "created_at": "2018-02-26 20:25:02"}
{"text": ["7", "Europe", "Dividend", "ETFs", "for", "Overseas", "Income"], "created_at": "2018-02-26 20:06:34"}
{"text": ["Novo", "Nordisk", "Expected", "to", "Report", "Flat", "Revenue", "in", "2018"], "created_at": "2018-02-26 18:55:02"}
{"text": ["Analysts\u2019", "Recommendations", "for", "Novo", "Nordisk", "and", "Peers", "in", "2018"], "created_at": "2018-02-26 17:24:26"}
{"text": ["Johnson", "&", "Johnson\u2019s", "Oncology", "Segment\u2019s", "Performance", "in", "2017"], "created_at": "2018-02-26 15:31:08"}
{"text": ["The", "Swiss", "Stock", "Market", "Climbed", "Back", "Above", "9,000", "Points"], "created_at": "2018-02-26 12:07:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Climbed", "Back", "Above", "9,000", "Points"], "created_at": "2018-02-26 12:07:00"}
